Joseph Daw, MD
Plastic and Reconstructive Surgery · Itasca, ILNPI 1982679015
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,970 of the $2,538 with a category attached, or 77.6%. It is spread thinly across 21 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.
Across 76 payments — averaging $33.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$550
- Lilly USA, LLC$356
- Bard Peripheral Vascular, Inc.$298
- Incyte Corporation$192
- Tepha Inc$192
- AbbVie$145
- plus $804 from 15 others
What the payments were for
- Consulting fees$171%
- Travel & lodging$55022%
- Food & beverage$1,97078%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 1 | $550 |
| Lilly USA, LLC | 15 | $356 |
| Bard Peripheral Vascular, Inc. | 2 | $298 |
| Incyte Corporation | 11 | $192 |
| Tepha Inc | 2 | $192 |
| AbbVie(2 entities) | 8 | $145 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Sun Pharmaceutical Industries Inc. | 5 | $104 |
| UCB, Inc. | 3 | $100 |
| Sanofi | 3 | $96 |
| Biofrontera Inc. | 5 | $73 |
| Johnson & Johnson | 3 | $62 |
| LEO Pharma Inc. | 2 | $40 |
| Mimedx Group, Inc. | 2 | $35 |
| Apyx Medical Corporation | 2 | $34 |
| Mayne Pharma Commercial LLC | 2 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $26 |
| Organogenesis Inc. | 1 | $25 |
| Pfizer | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Almirall LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GalaFLEX$153
How this compares
$2,538 in reported general payments places this provider in the 55th percentile of 126 plastic and reconstructive surgery providers in Illinois.
See all plastic and reconstructive surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 77 | $415 |
| Prednisolone Acetate | 11 | $379 |
| ErythromycinErythromycin Base | 15 | $102 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Itasca
- John KimChicago$7.3M
- Mark SiscoNorthbrook$309K
- Steven SigaloveGlen Ellyn$218K
- Matthew EndaraJoliet$204K
- Brian MaileySpringfield$182K
- Julius FewChicago$148K
- Eleanor BucholzMaywood$63K
- Gregory DumanianChicago$50K
- Daniel LiuZion$47K
- Laurie CasasGlenview$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.